BackTheseus Pharmaceuticals Overview

Theseus Pharmaceuticals EBIT

EBIT (Earnings Before Interest and Taxes) analysis for THRX.

Quarterly EBIT

-$16.43M
↓ 2.99% YoY

As of Sep 30, 2023

Annual EBIT (TTM)

-$66.59M
↓ 40.88% YoY

Trailing 12 months ending Sep 30, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin